VitroGel® Glioblastoma (GBM) Xeno-Free EMT Kit

Ready-to-use kit for 3D GBM tumoroid formation.
Supports epithelial-to-mesenchymal transition with long-term tumoroid culture.

SKU: VHM08-K Category:

VitroGel® VitroGel Glioblastoma (GBM) Xeno-Free EMT Kit

Ready-to-use kit for 3D GBM tumoroid formation, supporting epithelial-to-mesenchymal transition and enabling long-term tumoroid culture.

The VitroGel® Glioblastoma (GBM) Xeno-Free EMT Kit is an excellent tool for generating 3D GBM tumoroids, enabling cells to undergo the epithelial-to-mesenchymal transition for examining pathways involved in cancer metastasis, drug screening, and high-throughput automation.

The kit features the ready-to-use and synthetic VitroGel® EMT hydrogel, RocketCell™ GBM Xeno-Free EMT supplement (50X), and VitroPrime™ Ultra-Low Attachment, U-Bottom, 96-Well Plate.​

The VitroGel® Glioblastoma (GBM) Xeno-Free EMT Kit is designed to induce tumoroid formation from a simple single spheroid to generate a biologically relevant and well-organized tumoroid model for studying tumor progression, EMT dynamics, and therapeutic response in a preclinical setting.​

VitroGel® Glioblastoma (GBM) Xeno-Free EMT Kit (VHM08-K)
Contents:

  • 1 x 2 mL, VitroGel® EMT hydrogel
  • 1 x 5 mL, RocketCell™ GBM Xeno-Free EMT supplement (50X)
  • 1 x VitroPrime™ Ultra-Low Attachment Plate, U-Bottom, 96-Well

VitroGel® Glioblastoma (GBM) Xeno-Free EMT High-Screening Kit
(VHM08-HK)
Contents:

  • 5 x 2 mL, VitroGel® EMT hydrogel
  • 5 x 5 mL, RocketCell™ GBM Xeno-Free EMT supplement (50X)
  • 5 x VitroPrime™ Ultra-Low Attachment Plate, U-Bottom, 96-Well

Specifications

Use3D Glioblastoma tumoroid formation for drug screening purposes
FoormulationXeno-free, biofunctional hydrogel and supplement system
Injectability Injectable hydrogel for in vivo studies and lab automation​
Operation Ready-to-use at room temperature
Cell Harvesting VitroGel® Organoid Recovery Solution
5-15 min cell recovery
Shipping and StorageHydrogel: Ships at ambient temperature. Store at 2-8°C.

Supplement: Dry Ice shipping. Store at -20°C.
Challenges We Solve

Common Challenges in ​3D Tumoroid Generation​

How VitroGel® GBM Xeno-Free EMT Kit
Solves The Issues​

Product Documentation

 VitroGel® Glioblastoma (GBM) Xeno-Free EMT Kit – Sale Sheet

 Product Data Sheet

 Material Safety Data Sheet (MSDS)

Frequently Asked Questions 

Data and References

CASE 1

3D Tumoroid formation with the VitroGel® Glioblastoma Xeno-Free EMT Kit ​

Figure 1: VitroGel® Glioblastoma Xeno-Free EMT kit supports tumoroid formation.

U87 MG cells were resuspended in basal medium supplemented with 1X RocketCell™ GBM Xeno-Free EMT supplement and seeded into the VitroPrime™ Ultra-Low Attachment Plate, U-Bottom, 96-Well, to promote overnight spheroid formation. The spheroids were supplemented with VitroGel® EMT and RocketCell™ GBM Xeno-Free EMT supplement to induce tumoroid generation. Light microscopy was performed ​multiple days to evaluate tumoroid ​growth over time (left). Cyto3D® Live-Dead Assay staining was performed on GBM tumoroids. Live cells within the tumoroid are shown as green and dead cells in red (right).

CASE 2

Evaluation Viability of GBM Tumoroids

Figure 2: VitroGel® Glioblastoma Xeno-Free EMT kit hydrogel sustains tumoroid growth and viability.

GBM tumoroids were subjected to cell viability staining using Cyto3D® Live-Dead Assay Kit after six weeks in culture. The presence of live cells within the tumoroid is shown in green, and dead cells are shown in red. ​

CASE 3

Tumoroids grown with the VitroGel® Glioblastoma Xeno-Free EMT Kit
as a Platform for Drug Screening

Figure 3: GBM tumoroids are susceptible to chemotherapy.

Tumoroids were grown for 3 days in VitroGel® EMT hydrogel with RocketCell™ supplement ​system. The tumoroids were treated with Temozolomide (TMZ; 1mM) for 24 hours and subjected to cell viability studies. The Cyto3D® Live-Dead Assay Kit was used to label live cells (green) and dead cells (red) in the tumoroid, both with and without drug treatment. The pictures were obtained at a 20X magnification.

CASE 4

Tumoroid Characterization: Evaluation of EMT Markers

Figure 4: Assessing Vimentin expression, an EMT marker, in GBM tumoroids.

Immunofluorescence staining was employed on three-week-old tumoroids to examine ​Vimentin expression. The nuclei were stained with DAPI (blue), and vimentin staining is shown as green. A. Representative image of tumoroid topology and size (4X magnification). B-C. Enlarged images of vimentin-positive regions obtained with confocal microscope at 10X magnification.

Resources

Poster
Discerning the Role of the Extracellular Matrix on Epithelial-to-Mesenchymal Transition and Invasiveness of Glioblastoma Multiforme using a Xeno-Free 3D Hydrogel System

Quantity

1, 5